Pathogenesis of Postoperative Infections and Biomarkers for Early Diagnosis of it
- Sponsor
- National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
- Study ID
- NCT06513598
- Status
- Recruiting
Conditions
- Complication of Surgical Procedure
- Infections
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Major visceral surgery for gastrointestinal cancer — PROCEDUREThis is a longitudinal observational study of the patients undergoing major visceral surgery for gastrointestinal cancer. Biological samples will be collected to compare gastrointestinal and infection site metastases and develop biomarkers for postoperative infections.
Study Details
Infections remain a prevalent complication after major abdominal surgery. The common belief that most surgical site infections (SSIs) following elective surgery with modern antiseptic techniques are due to intraoperative contamination is still not confirmed. Therefore, alternative mechanisms for SSI development, such as the Trojan Horse theory-which suggests that pathogens from distant sites like the gastrointestinal tract may cause postoperative infections-should be explored. This study aims to analyze the preoperative microbiome of surgical patients' gut and oral cavities and assess whether microorganisms found there are present at the infection site. Additionally, this study will investigate a panel of biomarkers for predicting postoperative infections.
Key Dates
- First listed
- Jul 22, 2024
- Start date
- Jul 1, 2024
- Status verified
- Jul 2024
- Primary completion
- May 30, 2025
- Completion
- May 1, 2029
Study Design
- Enrollment
- 200 participants (estimated)
Primary Outcome Measure
The similarity in composition between the infection site microbiome and the gut/oral microbiome. [ Time Frame: 0 to 30 days ]
Central Contacts
- Augustinas Bausys37062214027
Related Studies
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- A Phase I Study of Mozobil in the Treatment of Patients With WHIMSPHASE1/PHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient OutcomesEnrolling By Invitation · Brigham and Women's Hospital · Boston, Massachusetts
- CIED Infection Quality Initiative Demonstration ProjectRecruiting · Duke University · Chicago, Illinois